يعرض 1 - 20 نتائج من 30,565 نتيجة بحث عن '(( c larger decrease ) OR ((( a ((step decrease) OR (_ decrease)) ) OR ( _ small decrease ))))', وقت الاستعلام: 0.82s تنقيح النتائج
  1. 1

    Effective contact rate over time for the different modelling scenarios considered: fixed, continuously increasing, continuously decreasing and with a step-decrease. حسب Joshua Looker (21390948)

    منشور في 2025
    "…<p>Effective contact rate over time for the different modelling scenarios considered: fixed, continuously increasing, continuously decreasing and with a step-decrease.</p>…"
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Algorithm operation steps. حسب Junyan Wang (4738518)

    منشور في 2025
    الموضوعات:
  8. 8

    Why does task performance decrease with burst length? حسب Swathi Anil (17382903)

    منشور في 2025
    "…See <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1013125#pcbi.1013125.s001" target="_blank">S1 Appendix</a>.…"
  9. 9
  10. 10
  11. 11
  12. 12

    The introduction of mutualisms into assembled communities increases their connectance and complexity while decreasing their richness. حسب Gui Araujo (22170819)

    منشور في 2025
    "…(D) As a result, the introduction of mutualistic interactions promotes a growth in complexity in communities where it was once established as low, while stopping the introduction of further mutualistic interactions causes a slight decrease in complexity. …"
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    DataSheet1_Decreasing viscosity and increasing accessible load by replacing classical diluents with a hydrotrope in liquid–liquid extraction.docx حسب Asmae El Maangar (19690522)

    منشور في 2025
    "…We show that using hydrotropes as a diluent decreases the viscosity of solutions by more than a factor of ten, even under high load by extracted cations. …"
  19. 19

    Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc حسب Lei Wang (6656)

    منشور في 2025
    "…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …"
  20. 20